FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KINDLER JEFFREY B
2. Issuer Name and Ticker or Trading Symbol

vTv Therapeutics Inc. [ VTVT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310
3. Date of Earliest Transaction (MM/DD/YYYY)

3/10/2020
(Street)

HIGH POINT, NC 27265
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 3/10/2020  M  11667.00 (1)A$0.00 35000.00 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (2)3/10/2020  M     11667.00   (3)3/10/2020 Class A Common Stock 11667.00 $0.00 0.00 D  

Explanation of Responses:
(1) Represents shares of Class A common stock issued upon vesting of 33.33% of the restricted stock units granted March 10, 2017.
(2) Each restricted stock unit represents a contingent right to receive one share of vTv Therapeutics Inc. Class A Common Stock
(3) The restricted stock units were granted on March 10, 2017 and vest in three equal installments beginning March 10, 2018.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
KINDLER JEFFREY B
C/O VTV THERAPEUTICS INC.
3980 PREMIER DRIVE, SUITE 310
HIGH POINT, NC 27265
X



Signatures
/s/ Rudy C. Howard, attorney-in-fact3/11/2020
**Signature of Reporting PersonDate

vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Jun 2020 to Jul 2020 Click Here for more vTv Therapeutics Charts.
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Jul 2019 to Jul 2020 Click Here for more vTv Therapeutics Charts.